What Is The Status Of The Latisse For Hair Loss Study?May 18th, 2011
Q: I saw your post on the clinical trials of Latisse (bimatoprost) for hair loss on the scalp. What is the status of the study? — B.V., New Providence, NJ
The first phase of the trials is now complete and the study has moved into phase II. In this phase, the pharmaceutical company will be studying the results of the same three formulations of the drug, but this time they will be comparing them to results of a control option and also an over-the-counter minoxidil 5% solution.
This study is scheduled to begin in June 2011 and end in September 2011. It is important to note that bimatoprost is not yet FDA approved for the treatment of scalp hair loss.
For more information, view the details of the study on ClinicalTrials.gov.
Read more about Latisse/Bimatoprost.Related Posts:
- Is the Dose of Finasteride the Same for Everyone?
- Does Propecia Work in Older Patients?
- Does Propecia Work for Life or Does it Stop Working Over Time?
- Is Propecia and/or Rogaine Mandatory after a Hair Transplant?
- Do Propecia (Finasteride) and Rogaine (Minoxidil) Work on Front of the Scalp?
Topic: Drugs (Medications)
Tags: Allergan, Androgenetic Alopecia, Food & Drug Administration (FDA), Hair Loss, Latisse for Hair Loss Study, Latisse/Bimatoprost, Male Pattern Baldness, Rogaine (Minoxidil), Safety Posted by Robert M. Bernstein M.D. on May 18th, 2011 at 6:10 pm